OMNISCAN Side Effects

7018454-3 | Gait Disturbance, Muscular Weakness, Pruritus
on Sep 10, 2010 Female patient from DENMARK , 65 years of age, was treated with Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: gait disturbance, muscular weakness, pruritus. Omniscan dosage: Single Dose.

7018281-7 | Gait Disturbance, Muscular Weakness, Pruritus
Patient was taking Omniscan (View Usage). Patient had the following side effects: gait disturbance, muscular weakness, pruritus on Sep 10, 2010 from DENMARK Additional patient health information: Female patient , 65 years of age, . Omniscan dosage: Single Dose.

7003855-X | Nephrogenic Systemic Fibrosis
Adverse event was reported on Sep 07, 2010 by a Female patient taking Omniscan (View Usage) (Dosage: Nr, Single Dose) . Location: DENMARK , 43 years of age, After Omniscan was administered, patient had the following side effects: nephrogenic systemic fibrosis.

6986115-2 | Azotaemia, Oliguria, Rectal Cancer
on Sep 03, 2010 Male patient from , 56 years of age, was treated with Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: azotaemia, oliguria, rectal cancer. Omniscan dosage: 12 Ml, Single Dose, I.v.. Patient was hospitalized.


6979471-2 | Nephrogenic Systemic Fibrosis
on Aug 31, 2010 Male patient from DENMARK , 58 years of age, weighting 160.9 lb, was diagnosed with myositis ossificans and was treated with Omniscan (View Usage). Patient had the following side effects: nephrogenic systemic fibrosis. Omniscan dosage: 50 Ml, Single Dose, I.v..

6975671-6 | Dizziness, Headache, Nausea, Nephrogenic Systemic Fibrosis
Patient was taking Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), nausea (What is nausea?), nephrogenic systemic fibrosis on Aug 30, 2010 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with dizziness (What is dizziness?), headache (What is headache?), nausea (What is nausea?), renal transplant, renal atrophy and. Omniscan dosage: 50 Ml, Single Dose, I.v., 16 Ml, Single Dose, I.v.. During the same period patient was treated with MULTIHANCE (15 Ml, Single Dose) (View Multihance Review and Multihance Label ).

6970427-2 | Aortic Valve Incompetence, Blood Creatinine Increased, Blood Phosphorus Increased, Cardiac Failure, Complications Of Transplanted Kidney, Gastrooesophageal Reflux Disease, Nephrogenic Systemic Fibrosis, Osteoarthritis
Adverse event was reported on Aug 27, 2010 by a Male patient taking Omniscan (View Usage) (Dosage: 40 Ml, Single Dose, I.v.) . Location: DENMARK , 53 years of age, weighting 187.4 lb, Patient experienced the following unwanted or unexpected effects: aortic valve incompetence, blood creatinine increased, blood phosphorus increased, cardiac failure, complications of transplanted kidney, gastrooesophageal reflux disease, nephrogenic systemic fibrosis, osteoarthritis (What is osteoarthritis?). During the same period patient was treated with MAGNEVIST (View Magnevist Review and Magnevist Label ), EPREX (View Eprex Review and Eprex Label ), SACCHARATED IRON OXIDE (VENOFER) (View Saccharated Iron Oxide (venofer) Review and Saccharated Iron Oxide (venofer) Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ISRADIPINE (LOMIR) (View Isradipine (lomir) Review and Isradipine (lomir) Label ), ALLOPURINOL (APURIN) (View Allopurinol (apurin) Review and Allopurinol (apurin) Label ), FUROSEMIDE (DIURAL) (View Furosemide (diural) Review and Furosemide (diural) Label ).

6970145-0 | Abdominal Pain, Activities Of Daily Living Impaired, Chills, Dyspnoea Exertional, Gait Disturbance, Hypotension, Nephrogenic Systemic Fibrosis, Vomiting
on Aug 27, 2010 Female patient from DENMARK , 36 years of age, weighting 100.3 lb, was treated with Omniscan (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), activities of daily living impaired, chills, dyspnoea exertional, gait disturbance, hypotension, nephrogenic systemic fibrosis, vomiting. Omniscan dosage: 40 Ml, Single Dose, I.v.. During the same period patient was treated with MEGLUMINE GADOTERATE (DOTAREM) (View Meglumine Gadoterate (dotarem) Review and Meglumine Gadoterate (dotarem) Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), INSULIN (View Insulin Review and Insulin Label ), ALFACALCIDOL (ETALPHA) (View Alfacalcidol (etalpha) Review and Alfacalcidol (etalpha) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized and became disabled.

6970143-7 | Gait Disturbance, Impaired Healing, Liver Disorder, Mitral Valve Incompetence, Osteoporosis, Pulmonary Function Test Abnormal, Restless Legs Syndrome, Sunburn
on Aug 27, 2010 Female patient from DENMARK , 36 years of age, weighting 143.3 lb, was treated with Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: gait disturbance, impaired healing, liver disorder, mitral valve incompetence, osteoporosis (What is osteoporosis?), pulmonary function test abnormal, restless legs syndrome, sunburn. Omniscan dosage: 30 Ml, Single Dose, I.v.; 40 Ml, Single Dose, I.v.. During the same period patient was treated with MEGLUMINE GADOTERATE (DOTAREM) (View Meglumine Gadoterate (dotarem) Review and Meglumine Gadoterate (dotarem) Label ), EPOETIN BETA (NEORECORMON) (View Epoetin Beta (neorecormon) Review and Epoetin Beta (neorecormon) Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ISRADIPINE (LOMIR) (View Isradipine (lomir) Review and Isradipine (lomir) Label ), VITAMINS (DILYSIS VITAMINS) (View Vitamins (dilysis Vitamins) Review and Vitamins (dilysis Vitamins) Label ), INSULIN (View Insulin Review and Insulin Label ).

6970134-6 | Abasia, Nephrogenic Systemic Fibrosis, Scleroderma
Patient was taking Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, nephrogenic systemic fibrosis, scleroderma (What is scleroderma?) on Aug 27, 2010 from DENMARK Additional patient health information: Male patient , 36 years of age, weighting 133.6 lb, was diagnosed with renal transplant and. Omniscan dosage: 30 Ml, Single Dose, I.v.. During the same period patient was treated with MEGLUMINE GADOTERATE (DOTAREM) (View Meglumine Gadoterate (dotarem) Review and Meglumine Gadoterate (dotarem) Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), DIALYSIS VITAMINS (View Dialysis Vitamins Review and Dialysis Vitamins Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized and became disabled.

6969034-7 | Arthralgia, Gait Disturbance, Nephrogenic Systemic Fibrosis, Pain In Extremity
Adverse event was reported on Aug 26, 2010 by a Male patient taking Omniscan (View Usage) (Dosage: 40 Ml, Single Dose, I.v.) . Location: DENMARK , 52 years of age, Patient had the following side effects: arthralgia, gait disturbance, nephrogenic systemic fibrosis, pain in extremity.

6969030-X | Gait Disturbance, Haemodialysis, Nephrogenic Systemic Fibrosis
on Aug 26, 2010 Male patient from DENMARK , 67 years of age, weighting 180.8 lb, was treated with Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: gait disturbance, haemodialysis, nephrogenic systemic fibrosis. Omniscan dosage: 50 Ml, Single Dose, I.v., 35 Ml, Single Dose, I.v.. Patient was hospitalized and became disabled.

6967628-6 | Activities Of Daily Living Impaired, Hypoaesthesia, Nephrogenic Systemic Fibrosis, Penile Ulceration, Restless Legs Syndrome
on Aug 25, 2010 Male patient from DENMARK , 51 years of age, weighting 209.4 lb, was diagnosed with complications of transplanted kidney and was treated with Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, hypoaesthesia, nephrogenic systemic fibrosis, penile ulceration, restless legs syndrome. Omniscan dosage: See Image.

6963704-2 | Arthralgia, Dermatophytosis, Fatigue, Gait Disturbance, Haemoglobin Decreased, Hypoaesthesia, Joint Stiffness, Joint Swelling, Limb Discomfort
Patient was taking Omniscan (View Usage). Patient had the following side effects: arthralgia, dermatophytosis, fatigue, gait disturbance, haemoglobin decreased, hypoaesthesia, joint stiffness, joint swelling, limb discomfort on Aug 18, 2010 from DENMARK Additional patient health information: Male patient , 66 years of age, was diagnosed with renal transplant and. Omniscan dosage: 20 Ml, Single Dose, I.v.. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), ALFACALCIDOL (ETAPLPHA) (View Alfacalcidol (etaplpha) Review and Alfacalcidol (etaplpha) Label ), VITAMIN B COMPLEX; PLAIN (B COMBIN ST?RK) (View Vitamin B-complex; Plain (b-combin St?rk) Review and Vitamin B-complex; Plain (b-combin St?rk) Label ), CALCIUM ACETATE (PHOS EX) (View Calcium Acetate (phos-ex) Review and Calcium Acetate (phos-ex) Label ), INNOHEP (View Innohep Review and Innohep Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), ERYTHROPOIETIN (NEORECORMON) (View Erythropoietin (neorecormon) Review and Erythropoietin (neorecormon) Label ).

6940204-7 | Gait Disturbance, Insomnia, Nephrogenic Systemic Fibrosis, Restlessness
Adverse event was reported on Aug 13, 2010 by a Male patient taking Omniscan (View Usage) (Dosage: Single Dose, I.v.) . Location: DENMARK , 58 years of age, After Omniscan was administered, patient had the following side effects: gait disturbance, insomnia, nephrogenic systemic fibrosis, restlessness. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), ALFACALCIDOL (ETALPHA) (View Alfacalcidol (etalpha) Review and Alfacalcidol (etalpha) Label ), SOTALOL (View Sotalol Review and Sotalol Label ), POLYSTYRENE SULFONATE (RESONIUM) (View Polystyrene Sulfonate (resonium) Review and Polystyrene Sulfonate (resonium) Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6940202-3 | Haemodialysis, Nephrogenic Systemic Fibrosis, Renal Transplant
on Aug 13, 2010 Female patient from DENMARK , 37 years of age, was treated with Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: haemodialysis, nephrogenic systemic fibrosis, renal transplant. Omniscan dosage: 40 Ml, Single Dose, I.v.. During the same period patient was treated with ERYTHROPOIETIN (NEORECORMON) (View Erythropoietin (neorecormon) Review and Erythropoietin (neorecormon) Label ), RAPAMUNE (View Rapamune Review and Rapamune Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), METOPROLOL SUCCINATE (SELO ZOK) (View Metoprolol Succinate (selo-zok) Review and Metoprolol Succinate (selo-zok) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (KALEORID) (View Potassium Chloride (kaleorid) Review and Potassium Chloride (kaleorid) Label ), ACETYLSALICYLIC ACID (HJERTEMAGNYL) (View Acetylsalicylic Acid (hjertemagnyl) Review and Acetylsalicylic Acid (hjertemagnyl) Label ), INSULIN HUMAN (ACTRAPID) (View Insulin Human (actrapid) Review and Insulin Human (actrapid) Label ).

6924476-0 | Cerebral Calcification, Headache, Nephrogenic Systemic Fibrosis
on Aug 04, 2010 Male patient from DENMARK , 48 years of age, weighting 191.8 lb, was diagnosed with renal transplant and was treated with Omniscan (View Usage). Patient had the following side effects: cerebral calcification, headache (What is headache?), nephrogenic systemic fibrosis. Omniscan dosage: Single Dose, I.v..

6917578-6 | Haemoglobin Decreased, Pleural Effusion, Rash Papular, White Blood Cell Count Increased
Patient was taking Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: haemoglobin decreased, pleural effusion, rash papular, white blood cell count increased on Aug 02, 2010 from INDIA Additional patient health information: Male patient , 22 years of age, weighting 114.6 lb, was diagnosed with convulsion and. Omniscan dosage: 13 Ml, Single Dose, I.v..

6917333-7 |
Adverse event was reported on Jul 21, 2010 by a Male patient taking Omniscan (View Usage) (Dosage: 10 Mg, Single Dose; 10 Ml, Single Dose; 10 Ml, Single Dose) . Location: UNITED STATES , 57 years of age, .

6894279-4 | Leg Amputation, Nephrogenic Systemic Fibrosis
on Jul 19, 2010 Male patient from DENMARK , 44 years of age, weighting 205.0 lb, was treated with Omniscan (View Usage). Patient had the following side effects: leg amputation, nephrogenic systemic fibrosis. Omniscan dosage: Single Dose, I.v..

6894278-2 | Arthralgia, Hypoaesthesia, Joint Stiffness, Joint Swelling, Limb Discomfort, Musculoskeletal Stiffness, Pain In Extremity, Paraesthesia, Sensory Disturbance
on Jul 21, 2010 Male patient from DENMARK , 66 years of age, was diagnosed with renal transplant and was treated with Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: arthralgia, hypoaesthesia, joint stiffness, joint swelling, limb discomfort, musculoskeletal stiffness, pain in extremity, paraesthesia, sensory disturbance. Omniscan dosage: 20 Ml, Single Dose, I.v.. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6876031-9 | Cardio-respiratory Arrest, Chest Pain, Hyperhidrosis
Patient was taking Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, chest pain (What is chest pain?), hyperhidrosis on Jul 12, 2010 from INDIA Additional patient health information: Male patient , 56 years of age, weighting 165.3 lb, was diagnosed with acute abdomen, pancreatitis and. Omniscan dosage: 80 Ml, Single Dose, I.v..

6875956-8 | Haemodialysis, Nephrogenic Systemic Fibrosis
Adverse event was reported on Jul 15, 2010 by a Male patient taking Omniscan (View Usage) (Dosage: 11.4 Ml, Singe Dose, I.v., 11.4 Ml (0.2 Ml/kg), Single Dose,i.v., Single Dose, I.v.) was diagnosed with acoustic neuroma (What is acoustic neuroma?), hydrocephalus (What is hydrocephalus?) and. Location: JAPAN , 53 years of age, weighting 125.7 lb, Patient had the following side effects: haemodialysis, nephrogenic systemic fibrosis.

6871137-2 | Anaemia, Creatinine Renal Clearance Decreased, Nephrogenic Systemic Fibrosis
on Jul 09, 2010 Male patient from BELGIUM , 31 years of age, weighting 209.4 lb, was diagnosed with renal transplant and was treated with Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: anaemia, creatinine renal clearance decreased, nephrogenic systemic fibrosis. Omniscan dosage: 19 Ml, I.e. 0.1 Mmol/kg, Single Dose, I.v.; 19 Ml, I.e. 0.1 Mmol/kg, Single Dose, I.v.. During the same period patient was treated with ENALAPRIL (View Enalapril Review and Enalapril Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), IMMUNOSUPPRESSIVE THERAPIES (View Immunosuppressive Therapies Review and Immunosuppressive Therapies Label ), EPOETIN ALFA (View Epoetin Alfa Review and Epoetin Alfa Label ), EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6865333-8 | Blister, Disease Progression, Nephrogenic Systemic Fibrosis
on Jul 09, 2010 Male patient from BELGIUM , 66 years of age, weighting 113.3 lb, was diagnosed with renal transplant and was treated with Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: blister, disease progression, nephrogenic systemic fibrosis. Omniscan dosage: 10.3 Ml, I.e. 0.1 Mmol/kg, Single Dose, I.v.. During the same period patient was treated with ERYTHROPOIETIN (EPOIETIN ALPHA) (View Erythropoietin (epoietin Alpha) Review and Erythropoietin (epoietin Alpha) Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), IMMUNOSUPPRESSIVE THERAPIES (View Immunosuppressive Therapies Review and Immunosuppressive Therapies Label ), IRON SUPPLEMENTATION (View Iron Supplementation Review and Iron Supplementation Label ). Patient was hospitalized and became disabled.

6865332-6 | Dialysis, Nephrogenic Systemic Fibrosis
Patient was taking Omniscan (View Usage). Patient had the following side effects: dialysis (What is dialysis?), nephrogenic systemic fibrosis on Jul 09, 2010 from BELGIUM Additional patient health information: Male patient , 55 years of age, weighting 189.6 lb, was diagnosed with renal transplant and. Omniscan dosage: See Image. During the same period patient was treated with MEGLUMINE GADOTERATE (DOTAREM) (View Meglumine Gadoterate (dotarem) Review and Meglumine Gadoterate (dotarem) Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6865305-3 | Metabolic Acidosis, Nephrogenic Systemic Fibrosis
Adverse event was reported on Jul 09, 2010 by a Male patient taking Omniscan (View Usage) (Dosage: 15 Ml, I.e. 0.1 Mmol/kg, Single Dose, I.v.) was diagnosed with renal transplant and. Location: BELGIUM , 60 years of age, weighting 165.3 lb, After Omniscan was administered, patient had the following side effects: metabolic acidosis, nephrogenic systemic fibrosis. During the same period patient was treated with IMMUNOSUPPRESSIVE THERAPIES (View Immunosuppressive Therapies Review and Immunosuppressive Therapies Label ), IRON SUPPLEMENTATION (View Iron Supplementation Review and Iron Supplementation Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ).

6865247-3 | Antiphospholipid Antibodies Positive, Creatinine Renal Clearance Decreased, Nephrogenic Systemic Fibrosis, Pruritus
on Jul 09, 2010 Male patient from BELGIUM , 26 years of age, weighting 110.2 lb, was diagnosed with renal transplant and was treated with Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: antiphospholipid antibodies positive, creatinine renal clearance decreased, nephrogenic systemic fibrosis, pruritus. Omniscan dosage: 10 Ml, I.e. 0.1 Mmol/kg, Single Dose, I.v.; 0.1 Mmol/kg, Single Dose, I.v.. During the same period patient was treated with EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), IMMUNOSUPPRESSIVE THERAPIES (View Immunosuppressive Therapies Review and Immunosuppressive Therapies Label ), LOSARTAN (View Losartan Review and Losartan Label ), EPOETIN ALPHA (View Epoetin Alpha Review and Epoetin Alpha Label ).

6839385-5 | Nephrogenic Systemic Fibrosis
on Jul 08, 2010 Male patient from SWITZERLAND , 20 years of age, was diagnosed with angiogram, renal scan, nuclear magnetic resonance imaging and was treated with Omniscan (View Usage). Patient had the following side effects: nephrogenic systemic fibrosis. Omniscan dosage: . During the same period patient was treated with PROHANCE (View Prohance Review and Prohance Label ).

6800964-2 | Nephrogenic Systemic Fibrosis
Patient was taking Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: nephrogenic systemic fibrosis on Jun 16, 2010 from DENMARK Additional patient health information: Male patient , 44 years of age, weighting 205.0 lb, . Omniscan dosage: Single Dose, I.v..

6800773-4 | Aortic Valve Incompetence, Aortic Valve Stenosis, Mitral Valve Calcification, Mitral Valve Incompetence, Nephrogenic Systemic Fibrosis, Pulmonary Function Test Abnormal
Adverse event was reported on Jun 22, 2010 by a Female patient taking Omniscan (View Usage) (Dosage: 15 Ml, Single Dose, I.v.) . Location: DENMARK , 55 years of age, Patient experienced the following unwanted or unexpected effects: aortic valve incompetence, aortic valve stenosis, mitral valve calcification, mitral valve incompetence, nephrogenic systemic fibrosis, pulmonary function test abnormal. During the same period patient was treated with MAGNEVIST (10 Ml, Single Dose, I.v.; 10 Ml, Single Dose, Intra-articular) (View Magnevist Review and Magnevist Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), QUININE (View Quinine Review and Quinine Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), REMERON (View Remeron Review and Remeron Label ), HALOPERIDOL (SERENASE) (View Haloperidol (serenase) Review and Haloperidol (serenase) Label ), EMPERAL (View Emperal Review and Emperal Label ).

6772217-2 | Dialysis, Joint Contracture, Joint Stiffness, Mobility Decreased, Nephrogenic Systemic Fibrosis, Oedema Peripheral, Respiratory Distress, Wheelchair User
on Jun 04, 2010 Male patient from NORWAY , 67 years of age, was diagnosed with renal cancer recurrent and was treated with Omniscan (View Usage). Patient had the following side effects: dialysis (What is dialysis?), joint contracture, joint stiffness, mobility decreased, nephrogenic systemic fibrosis, oedema peripheral, respiratory distress, wheelchair user. Omniscan dosage: 15 Ml, Single Dose, I.v.; 15 Ml, Single Dose, I.v.. During the same period patient was treated with MAGNEVIST (Singel Dose, 7 Examination With Magnevist Between 11/2001 And 10/2004) (View Magnevist Review and Magnevist Label ), ERYTHROPOI35IN ALFA (EPREX) (View Erythropoi35in Alfa (eprex) Review and Erythropoi35in Alfa (eprex) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SEVELAMER HYDROCHLORIDE (RENAGEL) (View Sevelamer Hydrochloride (renagel) Review and Sevelamer Hydrochloride (renagel) Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), PARENTROVITE (ORALOVITE) (View Parentrovite (oralovite) Review and Parentrovite (oralovite) Label ), DIPYRIDAMOLE (ASASANTIN RETARD) (View Dipyridamole (asasantin Retard) Review and Dipyridamole (asasantin Retard) Label ).

6770866-9 | Activities Of Daily Living Impaired, Nephrogenic Systemic Fibrosis
on Jun 04, 2010 Female patient from NORWAY , 38 years of age, was diagnosed with pituitary cyst and was treated with Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: activities of daily living impaired, nephrogenic systemic fibrosis. Omniscan dosage: Single Dose.

6770865-7 | Intestinal Obstruction, Localised Intraabdominal Fluid Collection, Peripheral Artery Dissection, Peritoneal Dialysis, Peritonitis Bacterial, Renal Transplant, Sclerosing Encapsulating Peritonitis, Serratia Infection
Patient was taking Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal obstruction, localised intraabdominal fluid collection, peripheral artery dissection, peritoneal dialysis, peritonitis bacterial, renal transplant, sclerosing encapsulating peritonitis, serratia infection on Jun 01, 2010 from BELGIUM Additional patient health information: Male patient , 67 years of age, was diagnosed with renal transplant and. Omniscan dosage: 20 Ml, Single Dose,.

6770864-5 | Renal Transplant, Sclerosing Encapsulating Peritonitis, Subileus
Adverse event was reported on Jun 01, 2010 by a Male patient taking Omniscan (View Usage) (Dosage: 20 Ml, Single Dose,) was diagnosed with renal transplant and. Location: BELGIUM , 61 years of age, Patient had the following side effects: renal transplant, sclerosing encapsulating peritonitis, subileus. Patient was hospitalized.

6761434-3 | Aortic Valve Incompetence, Aortic Valve Stenosis, Mitral Valve Calcification, Mitral Valve Incompetence, Nephrogenic Systemic Fibrosis, Pulmonary Function Test Abnormal
on May 26, 2010 Female patient from DENMARK , 60 years of age, was treated with Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: aortic valve incompetence, aortic valve stenosis, mitral valve calcification, mitral valve incompetence, nephrogenic systemic fibrosis, pulmonary function test abnormal. Omniscan dosage: 15 Ml, Single Dose, I.v.. During the same period patient was treated with MAGNEVIST (10 Ml, Single Dose, Intra-articular ; Single Dose ; Single Dose) (View Magnevist Review and Magnevist Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), QUININE (View Quinine Review and Quinine Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), REMERON (View Remeron Review and Remeron Label ).

6761383-0 | Hypoaesthesia, Joint Stiffness, Joint Swelling, Musculoskeletal Stiffness, Pain In Extremity, Paraesthesia, Sensory Disturbance
on May 25, 2010 Female patient from DENMARK , 66 years of age, was diagnosed with renal transplant and was treated with Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, joint stiffness, joint swelling, musculoskeletal stiffness, pain in extremity, paraesthesia, sensory disturbance. Omniscan dosage: 20 Ml, Single Dose, Iv. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6739464-7 | No Adverse Event
Patient was taking Omniscan (View Usage). Patient had the following side effects: no adverse event on May 13, 2010 from JAPAN Additional patient health information: Female patient , 71 years of age, . Omniscan dosage: Single Dose,.

6739447-7 | Arthralgia, Back Pain, Cellulitis, Deep Vein Thrombosis, Feeling Hot, Gait Disturbance, Haemodialysis, Haemoglobin Decreased, Hepatic Steatosis
Adverse event was reported on May 13, 2010 by a Female patient taking Omniscan (View Usage) (Dosage: 20 Ml, Single Dose, I.v.) was diagnosed with uterine polyp and. Location: JAPAN , 69 years of age, After Omniscan was administered, patient had the following side effects: arthralgia, back pain (What is back pain?), cellulitis (What is cellulitis?), deep vein thrombosis (What is deep vein thrombosis?), feeling hot, gait disturbance, haemodialysis, haemoglobin decreased, hepatic steatosis. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OLOPATADINE HYDROCHLORIDE (View Olopatadine Hydrochloride Review and Olopatadine Hydrochloride Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized and became disabled.

6738892-3 | No Adverse Event
on May 13, 2010 Male patient from JAPAN , 58 years of age, was treated with Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event. Omniscan dosage: Single Dose,.

6738890-X | Gait Disturbance, Nephrogenic Systemic Fibrosis
on May 13, 2010 Male patient from JAPAN , 53 years of age, weighting 125.7 lb, was diagnosed with acoustic neuroma (What is acoustic neuroma?), hydrocephalus (What is hydrocephalus?) and was treated with Omniscan (View Usage). Patient had the following side effects: gait disturbance, nephrogenic systemic fibrosis. Omniscan dosage: Single Dose, I.v.; 0.2 Ml/kg, Single Dose, I.v.; 0.2 Ml/kg, I.v..

6729836-9 | Aortic Valve Incompetence, Aortic Valve Stenosis, Dermatomyositis, Mitral Valve Calcification, Mitral Valve Incompetence, Nephrogenic Systemic Fibrosis, Pulmonary Function Test Abnormal
Patient was taking Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: aortic valve incompetence, aortic valve stenosis, dermatomyositis, mitral valve calcification, mitral valve incompetence, nephrogenic systemic fibrosis, pulmonary function test abnormal on May 06, 2010 from DENMARK Additional patient health information: Female patient , 55 years of age, . Omniscan dosage: 15 Ml, Single Dose, I.v.. During the same period patient was treated with MAGNEVIST (10 Ml, Single Dose, Intra-articular) (View Magnevist Review and Magnevist Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), QUININE (View Quinine Review and Quinine Label ), REMERON (View Remeron Review and Remeron Label ), HALOPERIDOL (SERENASE) (View Haloperidol (serenase) Review and Haloperidol (serenase) Label ).

6722781-4 | Bronchopulmonary Aspergillosis, Cerebral Aspergillosis, Coronary Artery Disease, Haemodialysis, Joint Contracture, Nephrogenic Systemic Fibrosis, Pneumonia Cytomegaloviral, Renal Transplant, Renal Vein Thrombosis
Adverse event was reported on May 04, 2010 by a Male patient taking Omniscan (View Usage) (Dosage: Single Dose, I.v. ; Single Dose, I.v. ; Single Dose, I.v. ; Single Dose, I.v.) . Location: GERMANY , 50 years of age, Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, cerebral aspergillosis, coronary artery disease (What is coronary artery disease?), haemodialysis, joint contracture, nephrogenic systemic fibrosis, pneumonia cytomegaloviral, renal transplant, renal vein thrombosis. During the same period patient was treated with MAGNEVIST (Single Dose ; Single Dose) (View Magnevist Review and Magnevist Label ), MEGLUMINE GADOTERATE (DOTAREM) (View Meglumine Gadoterate (dotarem) Review and Meglumine Gadoterate (dotarem) Label ), STEROIDS (View Steroids Review and Steroids Label ). Patient was hospitalized and became disabled.

6722780-2 | Gait Disturbance, Joint Stiffness, Joint Swelling, Lung Disorder, Nephrogenic Systemic Fibrosis, Pruritus, Scleroderma, Skin Atrophy, Skin Oedema
on May 03, 2010 Male patient from DENMARK , 36 years of age, was diagnosed with renal transplant and was treated with Omniscan (View Usage). Patient had the following side effects: gait disturbance, joint stiffness, joint swelling, lung disorder, nephrogenic systemic fibrosis, pruritus, scleroderma (What is scleroderma?), skin atrophy, skin oedema. Omniscan dosage: 30 Ml, Single Dose. During the same period patient was treated with MEGLUMINE GADOTERATE (DOTAREM) (View Meglumine Gadoterate (dotarem) Review and Meglumine Gadoterate (dotarem) Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), DIALYSIS VITAMINS (View Dialysis Vitamins Review and Dialysis Vitamins Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized and became disabled.

6722779-6 | Abdominal Abscess, Dupuytren's Contracture, Haemodialysis, Ileus, Metabolic Acidosis, Nephritis, Nephrogenic Systemic Fibrosis, Sepsis
on May 04, 2010 Female patient from GERMANY , 26 years of age, was diagnosed with psoas abscess, sepsis (What is sepsis?) and was treated with Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: abdominal abscess, dupuytren's contracture, haemodialysis, ileus, metabolic acidosis, nephritis, nephrogenic systemic fibrosis, sepsis (What is sepsis?). Omniscan dosage: See Image. Patient was hospitalized and became disabled.

6722778-4 | Dialysis, Nephrogenic Systemic Fibrosis
Patient was taking Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), nephrogenic systemic fibrosis on May 04, 2010 from GERMANY Additional patient health information: Female patient , 70 years of age, was diagnosed with grand mal convulsion, renal artery stenosis and. Omniscan dosage: 10 Ml, Single Dose, I.v.. During the same period patient was treated with MAGNEVIST (10 Ml, Single Dose, I.v.) (View Magnevist Review and Magnevist Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ). Patient was hospitalized and became disabled.

6714302-7 | Autoimmune Disorder, Disorder Of Orbit, Nephrogenic Anaemia, Nephrogenic Systemic Fibrosis, Pain In Extremity, Pyrexia, Renal Osteodystrophy
Adverse event was reported on Apr 22, 2010 by a Male patient taking Omniscan (View Usage) (Dosage: 10 Ml, Single Dose, I.v.; 10 Ml, I.v.; I.v.) was diagnosed with glaucoma (What is glaucoma?), retinal neoplasm and. Location: JAPAN , 14 years of age, Patient had the following side effects: autoimmune disorder, disorder of orbit, nephrogenic anaemia, nephrogenic systemic fibrosis, pain in extremity, pyrexia, renal osteodystrophy. During the same period patient was treated with EPOETIN (View Epoetin Review and Epoetin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), CEFMETAZOLE SODIUM (CEFMETAZON) (View Cefmetazole Sodium (cefmetazon) Review and Cefmetazole Sodium (cefmetazon) Label ). Patient was hospitalized and became disabled.

6714301-5 | Blood Lactate Dehydrogenase Decreased, Blood Parathyroid Hormone Increased, Haemoglobin Decreased, Nephrogenic Systemic Fibrosis, Red Blood Cell Count Decreased, White Blood Cell Count Decreased
on Apr 22, 2010 Male patient from JAPAN , 71 years of age, was diagnosed with peripheral ischaemia and was treated with Omniscan (View Usage). After Omniscan was administered, patient had the following side effects: blood lactate dehydrogenase decreased, blood parathyroid hormone increased, haemoglobin decreased, nephrogenic systemic fibrosis, red blood cell count decreased, white blood cell count decreased. Omniscan dosage: 15 Ml, Single Dose, I.v.. During the same period patient was treated with MAGNEVIST (View Magnevist Review and Magnevist Label ), CALCIUM CARBONATE (CALTAN) (View Calcium Carbonate (caltan) Review and Calcium Carbonate (caltan) Label ), CEFDINIR (CEFZON) (View Cefdinir (cefzon) Review and Cefdinir (cefzon) Label ), AMPICILLIN SODIUM W/SULBACTAM SODIUM (UNASYN S) (View Ampicillin Sodium W/sulbactam Sodium (unasyn S) Review and Ampicillin Sodium W/sulbactam Sodium (unasyn S) Label ), CEFTAZIDIME (MODACIN) (View Ceftazidime (modacin) Review and Ceftazidime (modacin) Label ), CEFOTIAM HYDROCHLORIDE (PANSPORIN) (View Cefotiam Hydrochloride (pansporin) Review and Cefotiam Hydrochloride (pansporin) Label ).

6714300-3 | Nephrogenic Systemic Fibrosis
on Apr 22, 2010 Female patient from JAPAN , 52 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Omniscan (View Usage). Patient experienced the following unwanted or unexpected effects: nephrogenic systemic fibrosis. Omniscan dosage: 7 Ml, Single Dose, I.v.. During the same period patient was treated with MAGNEVIST (View Magnevist Review and Magnevist Label ), SEVELAMER HYDROCHLORIDE (RENAGEL) (View Sevelamer Hydrochloride (renagel) Review and Sevelamer Hydrochloride (renagel) Label ), HEPARIN CALCIUM (CAPROCIN) (View Heparin Calcium (caprocin) Review and Heparin Calcium (caprocin) Label ). Patient was hospitalized and became disabled.

6714292-7 | Erythema, Haemodialysis, Morphoea, Nephrogenic Systemic Fibrosis, Pain Of Skin, Parakeratosis, Peritoneal Disorder, Pruritus, Scab
Patient was taking Omniscan (View Usage). Patient had the following side effects: erythema, haemodialysis, morphoea, nephrogenic systemic fibrosis, pain of skin, parakeratosis, peritoneal disorder, pruritus, scab (What is scab?) on Apr 22, 2010 from JAPAN Additional patient health information: Male patient , 24 years of age, weighting 136.7 lb, was diagnosed with malignant neoplasm of spinal cord and. Omniscan dosage: 10 Ml, Single Dose, I.v.. During the same period patient was treated with ALFACALCIDOL (ALFAROL) (View Alfacalcidol (alfarol) Review and Alfacalcidol (alfarol) Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), LISINOPRIL (LONGES) (View Lisinopril (longes) Review and Lisinopril (longes) Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), WASSER (View Wasser Review and Wasser Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), FERROUS SULFATE (FERO GRADUMET) (View Ferrous Sulfate (fero-gradumet) Review and Ferrous Sulfate (fero-gradumet) Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).